STING Agonist Cuts TNBC Tumor Recurrence and Extends Survival in Mice
Pharmaceutical STING activation reduced primary tumor recurrence and extended survival in a mouse model of metastatic triple negative breast cancer.
Pharmaceutical STING activation reduced primary tumor recurrence and extended survival in a mouse model of metastatic triple negative breast cancer.
Single-cell and spatial transcriptomics of mouse skin tumors reveal that myeloid-derived oncostatin M and TGFβ1 establish distinct stromal niches that ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.